STOP CLOPEZ CORP Recalls Schwinnng Capsules Due to Undeclared Nortadalafil

Editor
April 23, 2024
13:36
0 comments

Medical Recalls

Box of Schwinnng Capsules

CLOPEZ CORP is recalling a specific batch of Schwinnng capsules from the market. This recall is due to the discovery by the FDA that the Schwinnng capsules contain Nortadalafil which is a pharmaceutical compound commonly used in medications intended to address issues related to male erectile dysfunction. The identification of Nortadalafil in the Schwinnng capsules renders them unauthorized for distribution as it qualifies as an unapproved pharmaceutical substance. Consequently, the safety and effectiveness of the Schwinnng capsules have not been verified, prompting the necessity for their removal from circulation through a recall process.

This product is marketed as a dietary supplement for male sexual enhancement and is packaged and coded as follows:

SCHWINNNG Lot 2108 EXP 10/2024

The product was distributed Worldwide via Amazon.

STOP CLOPEZ CORP is issuing this press release to inform its customers about a recall of certain Schwinnng products. Customers who have purchased these products are advised to discontinue their use immediately. The company is facilitating the return process for all the recalled items. If you possess a Schwinnng product that is part of this recall, it is recommended to either destroy it or return it to STOP CLOPEZ CORP. The recalled Schwinnng products should include the foil from the blister pack, with any remaining pills, encompassing all lot codes. Additionally, customers are required to provide proof of purchase and their return address when sending back the product.

Source: FDA

Consumer Contact: -

Consumers with questions regarding this recall can contact Camila Lopez, STOP CLOPEZ CORP, by 786-580-5100 or by e-mail 12clopezl@gmail.com, between the hours of 10 a.m. and 5 p.m. Pacific Standard Time Monday-Friday, for instructions on the return and refund process. Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product.

Risk Statement: The Schwinnng products contain Nortadalafil, which may interact with nitrates found in some prescription drugs, such as nitroglycerin, and may cause a significant drop in blood pressure that may be life threatening. People with diabetes, high blood pressure, high cholesterol, or heart disease often take nitrates. Among the adult male population, who are most likely to use this product, adult males who use nitrates for cardiac conditions are most at risk.

Post Tags

Nortadalafil, Schwinnng, Schwinnng recall, STOP CLOPEZ CORP, STOP CLOPEZ CORP recall

Report a Problem With This Product

Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax.

Complete and submit the report Online
Regular Mail or Fax: Download form or call 1- 800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178
Complete a paper Voluntary MedWatch form that can be mailed to the FDA.
https://www.fda.gov/safety/report-problem-fda
Call an FDA Consumer Complaint Coordinator.